QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

S. 4519, Regulatory Modernization with Safety Trade-offs. Quorum's AI analysis reads it as a trade-off: gains for some, costs for others.

S. 4519 · Mixed

Prescription Drugs

What it does

This bill allows medical device manufacturers to provide required labeling (instructions, warnings, dosage information) exclusively in electronic form rather than on paper, provided users can easily access it online and request paper copies at no cost.

The analysis names pharmaceutical and medical device manufacturers (reduced printing, packaging, and distribution costs — and 2 more groups — among the beneficiaries.

The trade-off

Manufacturers may reduce paper labeling costs significantly, but users without internet access, digital literacy, or stable connectivity may not receive critical safety warnings, creating a two-tiered safety system.

Transparency scores 65%, with a medium warning level and no detached riders.

Who is behind it

Filed by Jim Banks. Cosponsored by John Hickenlooper.

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: QUORUM BILL ANALYSIS (LLM, FULL TEXT) · QUORUM BILL TRANSPARENCY ANALYSIS